Brian Kenneth Roberts - 02 Jul 2026 Form 4 Insider Report for Rezolute, Inc. (RZLT)

Reporting relationship: Chief Medical Officer
Issuer ticker: RZLT
Reported as of: 02 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jul 2026, 18:36:26 UTC
Prior SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Brian Kenneth Roberts

Key filing fact

Brian Kenneth Roberts filed Form 4 for Rezolute, Inc. (RZLT) on 07 Jul 2026.

Key facts

This page summarizes Brian Kenneth Roberts's Form 4 filing for Rezolute, Inc. (RZLT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 07 Jul 2026, 18:36.

Change

Previous filing in this sequence was filed on 04 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001829608 Primary reporting owner

ROBERTS BRIAN KENNETH

Relationship: Chief Medical Officer
Address: C/O REZOLUTE, INC., 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Signature: /s/ Brian Kenneth Roberts
Signature date: 07 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RZLT transaction

Common Shares

Tax liability

Transaction value
Shares: -3,062
Change %: -1%
Price: $4.99^*
Shares after: 293,851
Date: 02 Jul 2026
Ownership: Direct
Footnotes: F1

RZLT holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 15,500
Date: 02 Jul 2026
Ownership: Held in IRA

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The disposition reported on this Form 4 represents shares disposed of by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The disposition is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.